Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial decisions about a treatment for boys with Duchenne muscular dystrophy.

Vinay Prasad recently drew outrage from conservatives, including Laura Loomer, who disagreed with his approach to approving gene therapies for rare diseases and accused him of holding liberal views.

Indian-origin scientist Vinay Prasad resigned as the FDA's vaccine and gene therapy chief in just three months after backlash over halting Sarepta's DMD gene therapy on safety grounds. His caution drew criticism from patients,